Mercer Global Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Mercer Global Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Buy	+20	New	+$2.07K	﹤0.01%	5575

Other funds holding PPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Mercer Global Advisors's PPH Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 20 shares worth $2.19K. The stake represents ﹤0.01% of the portfolio and ranks #5575 among its holdings.

113 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Mercer Global Advisors held 20 shares of VanEck Pharmaceutical ETF worth $2.19K as of Q2 2026.
VanEck Pharmaceutical ETF was a new Mercer Global Advisors position in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5575 holding.
113 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.